Veeva Systems Inc.

NYSE:VEEV

Medical - Healthcare Information Services

Healthcare
$277.20 -1.83%

-$2.83 today

Market cap
$44.88B
Beta
0.95
P/E (TTM)
26.4
EPS (TTM)
$5.76
52W Low $148.05High $310.50

Volume 2.74M

Average 3.01M

VEEV Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Veeva Systems Inc.NYSE: VEEV

Net Income · Q2 FY2027 · quarter ended Jul 2026

Net income growth accelerates

Q2 FY2027 net income of $273.43M rose 36.5% year over year, ahead of the +25.3% change in trailing-twelve-month net income. Sequentially, it rose 4.8% from the prior quarter. Over 3 fiscal years it compounded at +23.1% a year.

Context

  • Net income amounted to 28.4% of revenue in FY2026, up 2.4 pp from a year earlier.
  • Net income increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 21 analysts of $1.54B (+69.5%) for the fiscal year ending Jan 2027, a step up from the +27.3% reported in FY2026.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
$273.43M+4.8% QoQ
Last fiscal yearJan 2026
$908.91M+27.3% YoY
LTMJul 2026
$1.01B+25.3% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+36.5%+60.5%+24.0 pp
1 year+27.3%+69.5%+42.3 pp
3-year CAGR+23.1%+27.7%+4.7 pp
5-year CAGR+21.7%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2026
908.91M USD
Year-over-year change
+27.3%
4-year CAGR
+20.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How VEEV compares with its peers on the latest reported figures

  • VEEV's LTM Jul 2026 net income of $1.01B is the 2nd largest of the 5 companies compared; the peer median is $91.87M.
  • Its year-over-year change of +25.3% is the 2nd highest of 5, against a peer median of +7.8%.
  • Net income amounts to 29.3% of revenue for VEEV, versus a peer median of 12.2%.
VEEV Competitors Peer median
Net Income for VEEV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$1.38B +11.5%+7.6%8.1%
VEEVVeeva Systems Inc.LTM Jul 2026$1.01B +25.3%+23.1%29.3%
DOCSDoximity, Inc.LTM Sep 2026$139.72M -44.8%+20.2%21.1%
SDGRSchrödinger, Inc.LTM Sep 2026$44.01M +125.0%-11.5%16.3%
HSTMHealthStream, Inc.LTM Mar 2026$19.92M +4.2%+14.9%6.4%
Peer median (excluding VEEV) $91.87M+7.8%+11.3%12.2%

Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Net Income427.39M487.71M525.71M714.14M908.91M
Depreciation & Amortization36.97M37.66M37.15M50.93M50.47M
Deferred Income Tax11.08M(127.5M)(105.37M)(112.27M)65.09M
Stock-Based Compensation0000472.7M
Change in Working Capital20.66M7.34M60.82M7.62M(91.94M)
Accounts Receivables(83.08M)(91.09M)(104M)(168.97M)(254.55M)
Inventory00000
Accounts Payables(3M)21.43M(10.23M)(1.96M)6.08M
Other Working Capital106.74M77M175.05M178.55M156.53M
Other Non-Cash Items268.37M375.26M393.03M429.64M9.99M
Operating Cash Flow764.46M780.47M911.34M1.09B1.42B
Capital Expenditures(14.21M)(13.51M)(26.2M)(20.52M)(29.13M)
Acquisitions (Net)(7.78M)0000
Purchases of Investments(1.12B)(2B)(2.7B)(2.58B)(3.13B)
Sales of Investments792.92M1B1.65B1.9B2.06B
Other Investing Activities00000
Investing Cash Flow(346.15M)(1.01B)(1.08B)(700.14M)(1.1B)
Debt Repayment(384K)0000
Common Stock Issued51.54M43.65M62.69M105.54M253.86M
Common Stock Repurchased0000(169.95M)
Dividends Paid00000
Other Financing Activities(55.29M)(63.03M)(78.88M)(79.42M)(93.25M)
Financing Cash Flow(4.14M)(19.38M)(16.19M)26.12M(9.33M)
Effect of Forex Changes(4.66M)(4.99M)(1.78M)(1.74M)919K
Net Change in Cash409.51M(251.58M)(182.98M)414.29M302.45M
Free Cash Flow750.25M766.96M885.14M1.07B1.39B

Veeva Systems Inc.

NYSE:VEEV

Intrinsic Alpha fair value

Locked

Current Price

$277.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.